Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Shares Outstanding (Weighted Average): 2017-2024

Historic Shares Outstanding (Weighted Average) for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $42.9 million.

  • DiaMedica Therapeutics' Shares Outstanding (Weighted Average) rose 18.25% to $14.1 million in Q4 2019 from the same period last year, while for Sep 2019 it was $12.0 million, marking a year-over-year increase of 1.42%. This contributed to the annual value of $42.9 million for FY2024, which is 12.92% up from last year.
  • As of FY2024, DiaMedica Therapeutics' Shares Outstanding (Weighted Average) stood at $42.9 million, which was up 12.92% from $38.0 million recorded in FY2023.
  • In the past 5 years, DiaMedica Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $42.9 million in FY2024 and a low of $18.8 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $38.0 million (2023), whereas its average is $35.8 million.
  • Data for DiaMedica Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY surged of 43.53% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows DiaMedica Therapeutics' Shares Outstanding (Weighted Average) stood at $18.8 million in 2020, then skyrocketed by 40.81% to $26.4 million in 2021, then increased by 0.01% to $26.4 million in 2022, then spiked by 43.53% to $38.0 million in 2023, then grew by 12.92% to $42.9 million in 2024.